PK assays help to select the dose for preclinical and clinical studies. Pharmacokinetic (PK) assays are used by pharmaceutical companies that want to understand the absorption, distribution, metabolism and excretion characteristics of chemical compounds. PK data allows companies to establish the dose for preclinical and clinical studies. During method validation, all factors that can possibly influence the validity of the data generated by the assay are taken into consideration. Scientists have to be clear on the ability of the assay to identify the drug in the sample matrix.
PK assays help in comparative analysis of originator and biosimilar products. The assays are used for the detection of monoclonal antibodies using anti-idiotypic antibodies. They are established and validated for therapeutic proteins with endogenous counterparts. The scientists have to distinguish the recombinant and endogenous protein. This helps in drug discovery and optimization process.
Patients of today and tomorrow are at an advantage. They now enjoy a better quality of life. The advancements in pharmacokinetic lead to better drug that are easily absorbed by the body to treat patients of various life threatening diseases. The research and new creations extend the lifespan of humans.
Drug discovery methods lead to creation of better drugs. Instead of taking four to five types of medicines that interact with each other in negative or positive ways, they can take only one. The body influences the absorption of drugs and discovering it leads to new drugs. Pharmaceuticals aim to enhance drug discovery and optimization using organic compounds which are small organic molecules and biologics. Computer aided drug designing is also making advancements. It is speeding up progress in biochemistry, molecular, and cell biology for speedy design and creation of new medicines. Research labs help with drug discovery by providing in vitro and in vivo contract research services.
For research data on PK assays, click here: http://www.alliancepharmaco.com/
PK assays help in comparative analysis of originator and biosimilar products. The assays are used for the detection of monoclonal antibodies using anti-idiotypic antibodies. They are established and validated for therapeutic proteins with endogenous counterparts. The scientists have to distinguish the recombinant and endogenous protein. This helps in drug discovery and optimization process.
Patients of today and tomorrow are at an advantage. They now enjoy a better quality of life. The advancements in pharmacokinetic lead to better drug that are easily absorbed by the body to treat patients of various life threatening diseases. The research and new creations extend the lifespan of humans.
Drug discovery methods lead to creation of better drugs. Instead of taking four to five types of medicines that interact with each other in negative or positive ways, they can take only one. The body influences the absorption of drugs and discovering it leads to new drugs. Pharmaceuticals aim to enhance drug discovery and optimization using organic compounds which are small organic molecules and biologics. Computer aided drug designing is also making advancements. It is speeding up progress in biochemistry, molecular, and cell biology for speedy design and creation of new medicines. Research labs help with drug discovery by providing in vitro and in vivo contract research services.
For research data on PK assays, click here: http://www.alliancepharmaco.com/